# A Study to Investigate the Effect of Steady-State TMC278 on the Pharmacokinetics of a Single Dose of Digoxin

> **NCT01519128** · PHASE1 · COMPLETED · sponsor: **Janssen R&D Ireland** · enrollment: 22 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Treatment A: Digoxin
- **DRUG:** Treatment B: TMC278

## Key facts

- **NCT ID:** NCT01519128
- **Lead sponsor:** Janssen R&D Ireland
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2013-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01519128

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01519128, "A Study to Investigate the Effect of Steady-State TMC278 on the Pharmacokinetics of a Single Dose of Digoxin". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01519128. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*